Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.

<h4>Background</h4>Treatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively. However, choice of treatments for breast cancer patients with negative stat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rajeshwari Mehta, Harshadadevi Katta, Fatouma Alimirah, Rutulkumar Patel, Genoveva Murillo, Xinjian Peng, Miguel Muzzio, Rajendra G Mehta
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/39d2c5de925e46dda68a3b55ca44f64b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/39d2c5de925e46dda68a3b55ca44f64b

Ejemplares similares